BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 27045006)

  • 1. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
    D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
    J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.
    Capietto AH; Kim S; Sanford DE; Linehan DC; Hikida M; Kumosaki T; Novack DV; Faccio R
    J Exp Med; 2013 Oct; 210(11):2257-71. PubMed ID: 24127488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
    Poh TW; Bradley JM; Mukherjee P; Gendler SJ
    Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation.
    Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY
    Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
    Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
    J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
    Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
    J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
    Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
    Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
    J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid suppressor cells and immune modulation in lung cancer.
    Srivastava MK; Andersson Å; Zhu L; Harris-White M; Lee JM; Dubinett S; Sharma S
    Immunotherapy; 2012 Mar; 4(3):291-304. PubMed ID: 22401635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
    Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
    Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment.
    Danelli L; Frossi B; Gri G; Mion F; Guarnotta C; Bongiovanni L; Tripodo C; Mariuzzi L; Marzinotto S; Rigoni A; Blank U; Colombo MP; Pucillo CE
    Cancer Immunol Res; 2015 Jan; 3(1):85-95. PubMed ID: 25351848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
    Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.
    Karakasheva TA; Waldron TJ; Eruslanov E; Kim SB; Lee JS; O'Brien S; Hicks PD; Basu D; Singhal S; Malavasi F; Rustgi AK
    Cancer Res; 2015 Oct; 75(19):4074-85. PubMed ID: 26294209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.
    Yu H; Liu Y; McFarland BC; Deshane JS; Hurst DR; Ponnazhagan S; Benveniste EN; Qin H
    Cancer Immunol Res; 2015 Jul; 3(7):727-40. PubMed ID: 25649351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid cell population dynamics in healthy and tumor-bearing mice.
    Ueha S; Shand FH; Matsushima K
    Int Immunopharmacol; 2011 Jul; 11(7):783-8. PubMed ID: 21406269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.